Data / Form D filings / AutoGenomics, Inc.
AutoGenomics, Inc.: Form D filings
AutoGenomics, Inc., a biotechnology company in Vista, CA, filed 16 Form D notices with the SEC between 2010 and 2013. The latest, on January 11, 2013, reports $165,600 sold of a $165,600 offering to 1 investor.
Find out what AutoGenomics, Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 2980 SCOTT STREET, Vista, CA, 92081
- Phone
- (760) 477-2248
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2008
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 504
- SEC identifier (CIK)
- 1439210
The full lists. Form D filings in California: 5,891 rows, $138.91, or the new rows each week for $19 a month. Form D filings in Biotechnology: 1,568 rows, $78.40, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, street, city, state, ZIP and 4 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jan 11, 2013 | New notice | $165,600 | $165,600 | $0 | 1 | Dec 27, 2012 | sec.gov |
| Jul 14, 2010 | New notice | $8,576,800 | $8,576,800 | $0 | 30 | Apr 15, 2010 | sec.gov |
| Jul 8, 2010 | Amendment | $18,867,294 | $17,632,595 | $1,234,699 | 67 | May 1, 2006 | sec.gov |
| Jul 8, 2010 | New notice | $100,000 | $100,000 | $0 | 3 | Dec 30, 2007 | sec.gov |
| Jul 8, 2010 | New notice | $20,000 | $20,000 | $0 | 2 | May 18, 2005 | sec.gov |
| Jul 7, 2010 | New notice | $5,054,117 | $5,054,117 | $0 | 60 | Nov 26, 2001 | sec.gov |
| Jun 8, 2010 | New notice | $274,000 | $274,000 | $0 | 1 | Jan 15, 2010 | sec.gov |
| Jun 8, 2010 | New notice | $30,000 | $30,000 | $0 | 1 | May 5, 2008 | sec.gov |
| Jun 8, 2010 | New notice | $11,125,589 | $11,125,589 | $0 | 50 | Dec 1, 2007 | sec.gov |
| Jun 8, 2010 | New notice | $75,000 | $75,000 | $0 | 1 | Mar 21, 2007 | sec.gov |
| Jun 8, 2010 | New notice | $6,473,478 | $6,473,478 | $0 | 14 | Feb 14, 2007 | sec.gov |
| Jun 3, 2010 | New notice | $1,121,400 | $1,121,400 | $0 | 5 | Feb 9, 2010 | sec.gov |
| Jun 2, 2010 | New notice | $10,751,014 | $10,751,014 | $0 | 2 | Jul 10, 2009 | sec.gov |
| Jun 2, 2010 | New notice | $14,111,640 | $14,111,640 | $0 | 23 | Mar 2, 2009 | sec.gov |
| Mar 25, 2010 | Amendment | $13,125,000 | $13,125,000 | $0 | 18 | Mar 9, 2010 | sec.gov |
| Mar 25, 2010 | New notice | $13,125,000 | $13,125,000 | $0 | 18 | Mar 9, 2010 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Shailendra V. Singh | Executive Officer | |
| Peter E. Wilding | Director | |
| Stephen V. Allison | Director | |
| Patrick V. Dillon | Executive Officer | |
| Thomas V. Hennessey, Jr. | Executive Officer, Director | |
| Donald E. Pogorzelski | Director | |
| Ramanath V. Vairavan | Executive Officer | |
| Laurence M. Demers | Director | |
| Charles V. Birmingham | Director | |
| Fareed Kureshy | Executive Officer, Director | |
| Eugene J. Zurlo | Director |
Other biotechnology companies in California that filed recently
- CARI Health, Inc. $280,000 · Nov 6, 2026
- Ausel, Inc. $120,000 · Nov 4, 2026
- Trellis Bioscience, Inc. $9.1 million · Oct 29, 2026
- BigHat Biosciences, Inc. $75.1 million · Oct 26, 2026
- Theravie Pharma, Inc. $750,000 · Oct 19, 2026
- Adela, Inc. $12 million · Oct 19, 2026
- Estuary Biotherapeutics, Inc. $40.7 million · Oct 16, 2026
- Renue Life Sciences, Inc. $250,000 · Oct 14, 2026
- Tempest Therapeutics, Inc. $7.5 million · Oct 14, 2026
- Lionheart Health, Inc. $387,500 · Oct 7, 2026
- Rakuten Medical, Inc. $9 million · Oct 6, 2026
- Zonaliz, Inc. $2.5 million · Oct 5, 2026
- Altay Therapeutics, Inc. $15.7 million · Oct 2, 2026
- Sialia Therapeutics, Inc. $1.5 million · Sep 29, 2026
- Vetmab Biosciences, Inc. $11.4 million · Sep 29, 2026
Every Form D from the week of Jan 7, 2013 · All recent filings in California · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what AutoGenomics, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.